Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

UniQure tumbles with latest data for Huntington’s gene therapy

Analysts guessed that investors wanted to see stronger durability results at a four-year check-in of the key trial supporting a potential approval of "AMT-130."

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

Kirinyaga Woman Rep Njeri pushes for endometriosis care to be included in UHC as women face delayed diagnosis

NAIROBI, Kenya, Sep 29 — Kirinyaga WomanRepresentative Maina Njeri has called for endometriosis to be treated as a public health and economic issue, urging the Government to integrate its diagnosis…

  • Kirinyaga Woman Rep Njeri advocates for endometriosis inclusion in Kenya’s UHC.
  • Endometriosis often leads to delayed diagnosis, causing suffering and financial hardship.
  • Njeri calls for government action on training, guidelines, and research for endometriosis care.

More from Tuesday 29 September →